Lloyds Engineering Works Regulatory Approval

Board Meeting Date

Lloyds Engineering Works Board Meeting Date

Lloyds Engineering Works schedules a 2 November 2026 board meeting to review unaudited standalone and consolidated results for September 2026. Trading window closed from 1 October.

Other Announcement

Lloyds Engineering Works Other Announcement

Lloyds Engineering Works Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.

Acquisition

Lloyds Engineering Works Acquisition

Lloyds Engineering Works Ltd held a court-convened shareholder meeting to approve the Scheme of Merger by absorption of three transferor companies. Voting results will be announced separately.

Merger & Restructuring

Lloyds Engineering Works Merger & Restructuring

Lloyds Engineering Works held a court-convened meeting to seek shareholder approval for the proposed merger by absorption of three transferor companies into the entity.

Share Pledge

Lloyds Engineering Works Share Pledge

Lloyds Enterprises Limited created a pledge on 1.10 crore equity shares of Lloyds Engineering Works Limited in favour of Aditya Birla Capital Limited.

Employee Stock Options

Lloyds Engineering Works Employee Stock Options

Lloyds Engineering Works granted 22,52,050 employee stock options to eligible employees of the company and its subsidiary under the ESOP 2021 plan at ₹9.50 per option.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.